Key Financial Data Of Reporting Company

Chiome Bioscience Inc. - Filing #7270994

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
780,809,000 JPY
682,464,000 JPY
630,815,000 JPY
712,932,000 JPY
480,853,000 JPY
Ordinary profit (loss)
-1,019,210,000 JPY
-1,217,240,000 JPY
-1,243,838,000 JPY
-1,329,312,000 JPY
-1,291,606,000 JPY
Profit (loss)
-1,020,776,000 JPY
-1,220,018,000 JPY
-1,242,871,000 JPY
-1,479,895,000 JPY
-1,293,798,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
JPY
JPY
Share capital
995,525,000 JPY
2,388,422,000 JPY
2,097,017,000 JPY
1,515,929,000 JPY
1,387,677,000 JPY
Total number of issued shares
66,969,000 xbrli:shares
52,640,200 xbrli:shares
48,423,500 xbrli:shares
40,781,500 xbrli:shares
39,505,200 xbrli:shares
Net assets
1,920,303,000 JPY
1,157,723,000 JPY
1,790,746,000 JPY
1,893,049,000 JPY
3,109,968,000 JPY
Total assets
2,468,857,000 JPY
1,751,454,000 JPY
2,215,470,000 JPY
2,339,439,000 JPY
3,494,554,000 JPY
Net assets per share
28.53
21.66
36.70
45.55
77.99
Dividend paid per share
Interim dividend paid per share
Basic earnings (loss) per share
-17.54
-24.62
-28.26
-36.74
-36.06
Diluted earnings per share
Equity-to-asset ratio
0.774 xbrli:pure
0.651 xbrli:pure
0.802 xbrli:pure
0.794 xbrli:pure
0.882 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Payout ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-1,000,695,000 JPY
-1,069,192,000 JPY
-1,191,009,000 JPY
-1,131,291,000 JPY
-1,360,143,000 JPY
Net cash provided by (used in) investing activities
JPY
173,000 JPY
JPY
-35,384,000 JPY
-3,519,000 JPY
Net cash provided by (used in) financing activities
1,738,421,000 JPY
667,303,000 JPY
1,127,291,000 JPY
271,345,000 JPY
1,944,005,000 JPY
Cash and cash equivalents
2,063,280,000 JPY
1,325,554,000 JPY
1,727,270,000 JPY
1,790,988,000 JPY
2,686,318,000 JPY
Number of employees
47 xbrli:pure
9 xbrli:pure
38 xbrli:pure
51 xbrli:pure
49 xbrli:pure
49 xbrli:pure
42 xbrli:pure
Average number of temporary employees
18 xbrli:pure
4 xbrli:pure
14 xbrli:pure
17 xbrli:pure
14 xbrli:pure
13 xbrli:pure
14 xbrli:pure
Total shareholder return
1.332 xbrli:pure
0.668 xbrli:pure
0.881 xbrli:pure
0.965 xbrli:pure
0.921 xbrli:pure
Total return on share price index
0.919 xbrli:pure
0.993 xbrli:pure
1.034 xbrli:pure
1.101 xbrli:pure
1.333 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.